Joubert syndrome and related disorders

Joubert syndrome and related disorders (JSRD) represent a group of rare genetic conditions characterized by a distinctive brain malformation known as the "molar tooth sign" (MTS), visible on axial brain MRI. This hallmark finding results from cerebellar vermis hypoplasia, deepened interpeduncular fossa, and thickened, elongated superior cerebellar peduncles. Joubert syndrome (JS) was first described in 1969 and is the prototypical ciliopathy — a disorder caused by dysfunction of primary cilia, which are cellular structures critical for signaling during embryonic development. Over 40 causative genes have been identified, most encoding proteins localized to the primary cilium or its basal body. The core clinical features of JSRD include hypotonia in infancy, cerebellar ataxia, developmental delay or intellectual disability, and abnormal eye movements (particularly oculomotor apraxia). Many affected individuals also exhibit an abnormal breathing pattern in the neonatal period, characterized by episodes of hyperpnea (rapid breathing) alternating with apnea. Beyond the central nervous system, JSRD can affect multiple organ systems depending on the specific genetic subtype. These associated features include retinal dystrophy (leading to progressive vision loss), renal disease (nephronophthisis or cystic kidney disease), hepatic fibrosis, polydactyly, coloboma, and encephalocele. The specific combination of extra-neurological features has historically led to the designation of several related syndromes, including COACH syndrome (cerebellar vermis hypoplasia, oligophrenia, ataxia, coloboma, hepatic fibrosis), Dekaban-Arima syndrome, and Joubert syndrome with oculorenal involvement. There is currently no cure for Joubert syndrome and related disorders. Management is supportive and multidisciplinary, focusing on early intervention therapies (physical, occupational, and speech therapy), monitoring and treatment of kidney and liver complications, ophthalmologic surveillance, and management of breathing abnormalities. Regular screening for renal function decline is particularly important, as nephronophthisis can progress to end-stage kidney disease. Genetic counseling is recommended for affected families, and prenatal diagnosis is available when the familial mutation is known.

Common questions about Joubert syndrome and related disorders